Germany Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • ID: 4342752
  • Report
  • Region: Germany
  • 162 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Baxter International Inc
  • Boehringer Ingelheim GmbH
  • Edwards Lifesciences Corp
  • GlaxoSmithKline Plc
  • Medtronic Plc
  • MORE
Germany Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Summary

The new report, "Germany Drug Delivery Devices Market Outlook to 2023", provides key market data on the Germany Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Drug Delivery Devices market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the Germany Drug Delivery Devices market.
  • Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.
Reasons to buy
  • Develop business strategies by identifying the key market categories poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Baxter International Inc
  • Boehringer Ingelheim GmbH
  • Edwards Lifesciences Corp
  • GlaxoSmithKline Plc
  • Medtronic Plc
  • MORE
1 Table of Contents
2 Introduction
2.1 What Is This Report About?
2.2 Drug Delivery Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Drug Delivery Devices Market, Germany
3.1 Drug Delivery Devices Market, Germany, Revenue ($m), 2009-2023
3.2 Drug Delivery Devices Market, Germany, Revenue Mix ($m), 2016
3.3 Drug Delivery Devices Market, Germany, Category Contribution by Revenue ($m), 2016
3.4 Drug Delivery Devices Market, Germany, Category Comparison by Revenue ($m), 2009-2023
3.5 Drug Delivery Devices Market, Germany, Revenue ($m), 2009-2016
3.6 Drug Delivery Devices Market, Germany, Revenue ($m), 2016-2023
3.7 Drug Delivery Devices Market, Germany, Volume (Units), 2009-2023
3.8 Drug Delivery Devices Market, Germany, Volume (Units), 2009-2016
3.9 Drug Delivery Devices Market, Germany, Volume (Units), 2016-2023
3.10 Drug Delivery Devices Market, Germany, Company Share by Revenue ($m), 2016
4 Central Venous Catheters Market, Germany
4.1 Central Venous Catheters Market, Germany, Revenue Mix ($m), 2016
4.2 Central Venous Catheters Market, Germany, Segment Contribution (%), 2016
4.1 Central Venous Catheters Market, Germany, Revenue ($m), 2009-2016
4.2 Central Venous Catheters Market, Germany, Revenue ($m), 2016-2023
4.3 Central Venous Catheters Market, Germany, Volume (Units), 2009-2016
4.4 Central Venous Catheters Market, Germany, Volume (Units), 2016-2023
4.6 Central Venous Catheters Market, Germany, Distribution Share by Revenue ($m), 2015-2016
4.7 Central Venous Catheters Market, Germany, Company Share by Revenue ($m), 2016
5 Infusion Systems Market, Germany
5.1 Infusion Systems Market, Germany, Revenue Mix ($m), 2016
5.2 Infusion Systems Market, Germany, Segment Contribution (%), 2016
5.3 Infusion Systems Market, Germany, Revenue ($m), 2009-2016
5.4 Infusion Systems Market, Germany, Revenue ($m), 2016-2023
5.4.1 Ambulatory Infusion Pumps Market, Germany, Revenue ($m), by Segment, 2009-2016
5.4.2 Syringe Pumps Market, Germany, Revenue ($m), by Segment, 2009-2016
5.4.3 Ambulatory Infusion Pumps Market, Germany, Revenue ($m), by Segment, 2016-2023
5.4.4 Syringe Pumps Market, Germany, Revenue ($m), by Segment, 2016-2023
5.5 Infusion Systems Market, Germany, Volume (Units), 2009-2016
5.6 Infusion Systems Market, Germany, Volume (Units), 2016-2023
5.6.1 Ambulatory Infusion Pumps Market, Germany, Volume (Units), by Segment, 2009-2016
5.6.2 Syringe Pumps Market, Germany, Volume (Units), by Segment, 2009-2016
5.6.3 Ambulatory Infusion Pumps Market, Germany, Volume (Units), by Segment, 2016-2023
5.6.4 Syringe Pumps Market, Germany, Volume (Units), by Segment, 2016-2023
5.7 Infusion Systems Market, Germany, Distribution Share by Revenue ($m), 2015-2016
5.8 Infusion Systems Market, Germany, Company Share by Revenue ($m), 2016
6 Metered Dose Inhaler Devices Market, Germany
6.1 Metered Dose Inhaler Devices Market, Germany, Revenue ($m), 2009-2016
6.2 Metered Dose Inhaler Devices Market, Germany, Revenue ($m), 2016-2023
6.3 Metered Dose Inhaler Devices Market, Germany, Volume (Units), 2009-2016
6.4 Metered Dose Inhaler Devices Market, Germany, Volume (Units), 2016-2023
6.5 Metered Dose Inhaler Devices Market, Germany, Distribution Share by Revenue ($m), 2015-2016
6.6 Metered Dose Inhaler Devices Market, Germany, Company Share by Revenue ($m), 2016
7 Needle Free Injections Market, Germany
7.1 Needle Free Injections Market, Germany, Revenue ($m), 2009-2016
7.2 Needle Free Injections Market, Germany, Revenue ($m), 2016-2023
7.3 Needle Free Injections Market, Germany, Volume (Units), 2009-2016
7.4 Needle Free Injections Market, Germany, Volume (Units), 2016-2023
7.5 Needle Free Injections Market, Germany, Distribution Share by Revenue ($m), 2015-2016
7.6 Needle Free Injections Market, Germany, Company Share by Revenue ($m), 2016
8 Overview of Key Companies in Germany, Drug Delivery Devices Market
8.1 B. Braun Melsungen AG
8.1.1 Company Overview
8.2 Teleflex Inc
8.2.1 Company Overview
8.3 GlaxoSmithKline Plc
8.3.1 Company Overview
8.4 C. R. Bard Inc
8.4.1 Company Overview
8.5 Edwards Lifesciences Corp
8.5.1 Company Overview
8.6 AstraZeneca Plc
8.6.1 Company Overview
8.7 Boehringer Ingelheim GmbH
8.7.1 Company Overview
8.8 Pfizer Inc
8.8.1 Company Overview
8.9 Baxter International Inc
8.9.1 Company Overview
8.10 Merck & Co Inc
8.10.1 Company Overview
8.11 Becton Dickinson and Co
8.11.1 Company Overview
8.12 Fresenius Kabi AG
8.12.1 Company Overview
8.13 Smiths Medical
8.13.1 Company Overview
8.14 Medtronic Plc
8.14.1 Company Overview
8.15 Nipro Corp
8.15.1 Company Overview
8.16 Hospira Inc
8.16.1 Company Overview
8.17 Terumo Corp
8.17.1 Company Overview
9 Drug Delivery Devices Market Pipeline Products
10 Financial Deals Landscape
10.1 Acquisition
10.1.1 Dietmar Hopp May Sell its Stake in LTS Lohmann Therapie-Systeme
10.1.2 Luye Pharma Acquires Acino and Acino Supply for USD269 Million
10.2 Asset Transactions
10.2.1 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer
10.3 Debt Offerings
10.3.1 Fresenius Raises USD742.5 Million in Private Placement of 0.875% Notes Due 2022
10.3.2 Fresenius Raises USD742.5 Million in Private Placement of 1.5% Notes Due 2024
10.3.3 Fresenius Raises USD742.5 Million in Private Placement of 2.125% Notes Due 2027
10.3.4 Fresenius Raises USD530.4 Million in Private Placement of 3% Notes Due 2032
10.4 Equity Offerings
10.4.1 Magforce Raises USD5.6 Million in Private Placement of Shares
10.5 Partnerships
10.5.1 Alimera Sciences Enters into Licensing Agreement with pSivida
10.5.2 Vetter Pharma International and Microdermics Enter into Agreement
10.5.3 Ferring International and Alrise Biosystems Enter into Co-Development Agreement
10.5.4 Bluegrass Vascular Enters into Partnership with Merit Medical
10.5.5 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs
10.5.6 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
10.5.7 Propeller Health Enters into Agreement with Novartis Pharma
10.5.8 Neuronex Enters Into Licensing Agreement With SK Biopharmaceuticals For DZNS Technology
10.5.9 Pfizer Terminates its Licensing Agreement with pSivida
10.5.10 BioMed X Enters into Agreement with Merck
10.5.11 Bayer Enters into Licensing Agreement with DelSiTech
10.5.12 BioCorRx Enters into Licensing Agreement with Therakine
10.6 Venture Financing
10.6.1 AMW Raises USD6.4 Million in Venture Financing
11 Recent Developments
11.1 Corporate Communications
11.1.1 Jun 29, 2017: Bernhard Kernen named CFO of Raumedic
11.1.2 Jun 27, 2017: NOVALIQ Strengthens Executive Management Team with the Appointment of Gabriela Burian, MD, MPH, as Chief Medical Officer
11.1.3 May 12, 2017: Constantin Birnstiel to Become Head of Group Communications at Merck
11.1.4 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board
11.1.5 Apr 05, 2017: New member of the Executive Board appointed
11.1.6 Mar 28, 2017: Vetter’s Dr. Claudia Roth is appointed to the Fraunhofer Advisory Board
11.1.7 Feb 22, 2017: Change in the B. Braun Management Board
11.1.8 Feb 07, 2017: Haselmeier Appoints Paul Jansen as Senior Advisor and Member of the Board of Directors
11.1.9 Jan 13, 2017: Fresenius Medical Care Announces Leadership Change in North America
11.1.10 Jan 09, 2017: leon Appoints Pharma Expert Michael Mehler as Chief Executive Officer
11.1.11 Jan 09, 2017: leon-nanodrugs Appoints Pharma Expert Michael Mehler as Chief Executive Officer
11.1.12 Oct 31, 2016: TCT 2016: Orsiro Drug-Eluting Stent Proves Non-Inferiority to Resolute Integrity and Synergy Stents
11.1.13 Sep 23, 2016: Merck Appoints Isabel De Paoli as Chief Strategy Officer
11.1.14 Aug 10, 2016: MagForce announces positive results of 2016 Annual General Meeting
11.1.15 Jul 22, 2016: LTS Lohmann Therapie-Systeme Appoints New Chief TechOps Officer
11.2 Financial Announcements
11.2.1 Jun 30, 2017: MagForce Publishes Financial Results for the Year 2016 and Operative Highlights
11.2.2 May 18, 2017: Merck Continues to Grow Profitably in the First Quarter
11.2.3 Apr 05, 2017: Successful financial year 2016 for Boehringer Ingelheim
11.2.4 Mar 31, 2017: B. Braun continues its sales and earnings growth
11.2.5 Oct 27, 2016: Fresenius: Continued strong sales and earnings growth; Lower end of Group earnings guidance raised
11.2.6 Sep 30, 2016: MagForce Publishes Financial Results for the First Half of 2016 and Operative Highlights
11.2.7 Aug 04, 2016: Merck Lifts Forecast Following Good Second Quarter
11.2.8 Aug 01, 2016: Fresenius Medical Care posts accelerated earnings growth in the 2nd quarter
11.3 Legal And Regulatory
11.3.1 Jan 31, 2017: Fresenius Medical Care reaches agreement on outstanding payments
11.3.2 Dec 13, 2016: TUV Certification for the Bengaluru Facility
11.3.3 Nov 30, 2016: New Vetter data processing center is officially certified
11.4 Other Significant Developments
11.4.1 Jul 12, 2017: Merck Refines Western European Life Science Production Site Network
11.4.2 Jul 12, 2017: Fresenius Medical Care successfully amends and extends its credit agreement, ahead of schedule
11.4.3 Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund
11.4.4 Apr 28, 2017: MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations
11.4.5 Mar 21, 2017: Merck Accelerator Hits New Peak of Applications
11.4.6 Mar 10, 2017: Fresenius Kabi builds new warehouse at Blonie production site
11.4.7 Mar 09, 2017: Merck Generates Record Sales and Continues to Grow Profitably in 2016
11.4.8 Nov 15, 2016: Merck Raises Profit Forecast for 2016 Following Good Third Quarter
11.4.9 Oct 11, 2016: Fresenius Kabi Joins Chicago Health Innovation Incubator MATTER as Newest Strategic Partner
11.4.10 Aug 17, 2016: Fresenius Kabi investing nearly $250 million to expand plant near Chicago
11.4.11 Aug 03, 2016: Boehringer Ingelheim: Growth in all core businesses
11.4.12 Jul 19, 2016: MilliporeSigma Starts Construction on $115 Million Multi-faceted Life Science Campus in Burlington, Massachusetts
11.5 Product News
11.5.1 May 03, 2017: B. Braun Focused on Peripheral Vascular Access & Hazardous Drug Safety at INS
11.6 Strategy And Business Planning
11.6.1 Jul 06, 2017: Fresenius Kabi expands production site in Portugal
11.6.2 Jun 29, 2017: Merck Expands Packaging Capacity at Swiss Biotech Manufacturing Site of Aubonne
11.6.3 Jun 20, 2017: Merck Ventures Creates New Immuno-Oncology Company iOnctura
11.6.4 Jun 08, 2017: Fresenius Medical Care sees excellent prospects for further growth and launches a new Global Efficiency Program at its Capital Markets Day 2017
11.6.5 May 16, 2017: Merck: Optimizing the Further Development of the Darmstadt Site
11.6.6 Apr 20, 2017: Merck Provides Upgraded Manufacturing Capabilities to BioInvent with Single-use Mobius Bioreactors
11.6.7 Feb 16, 2017: GSK and EMBL have signed an agreement to enhance understanding of disease and drug mechanisms
11.6.8 Nov 22, 2016: HELIOS lays foundation stone for new hospital building in Wiesbaden
11.6.9 Oct 13, 2016: Merck Sets its Sights on 2018 and Outlines Future Strategic Roadmap
12 Appendix
12.1 Research Methodology
12.1.1 Coverage
12.1.2 Secondary Research
12.1.3 Primary Research
12.1.4 Company Share Analysis
12.1.5 Distribution Share Analysis
12.1.6 Benchmarking
12.2 Consulting
12.3 Contact
12.4 Disclaimer

List of Tables
Table 1: Drug Delivery Devices Market, Germany, Revenue ($m), USD Constant, 2009-2023
Table 2: Drug Delivery Devices Market, Germany, Category Contribution by Revenue ($m), 2016
Table 3: Drug Delivery Devices Market, Germany, Category Comparison by Revenue ($m), 2009-2023
Table 4: Drug Delivery Devices Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
Table 5: Drug Delivery Devices Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 6: Drug Delivery Devices Market, Germany, Volume (Units), 2009-2023
Table 7: Drug Delivery Devices Market, Germany, Volume (Units), Historic, 2009-2016
Table 8: Drug Delivery Devices Market, Germany, Volume (Units), Forecast, 2016-2023
Table 9: Drug Delivery Devices Market, Germany, Company Share by Revenue ($m), USD Constant, 2016
Table 10: Central Venous Catheters Market, Germany, Segment Contribution (%), 2016
Table 11: Central Venous Catheters Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
Table 12: Central Venous Catheters Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 13: Central Venous Catheters Market, Germany, Volume (Units), Historic, 2009-2016
Table 14: Central Venous Catheters Market, Germany, Volume (Units), Forecast, 2016-2023
Table 15: Central Venous Catheters Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 16: Central Venous Catheters Market, Germany, Company Share by Revenue ($m), USD Constant, 2016
Table 17: Infusion Systems Market, Germany, Segment Contribution (%), 2016
Table 18: Infusion Systems Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
Table 19: Infusion Systems Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 20: Ambulatory Infusion Pumps Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
Table 21: Syringe Pumps Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
Table 22: Ambulatory Infusion Pumps Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 23: Syringe Pumps Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 24: Infusion Systems Market, Germany, Volume (Units), Historic, 2009-2016
Table 25: Infusion Systems Market, Germany, Volume (Units), Forecast, 2016-2023
Table 26: Ambulatory Infusion Pumps Market, Germany, Volume (Units), Historic, 2009-2016
Table 27: Syringe Pumps Market, Germany, Volume (Units), Historic, 2009-2016
Table 28: Ambulatory Infusion Pumps Market, Germany, Volume (Units), Forecast, 2016-2023
Table 29: Syringe Pumps Market, Germany, Volume (Units), Forecast, 2016-2023
Table 30: Infusion Systems Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 31: Infusion Systems Market, Germany, Company Share by Revenue ($m), USD Constant, 2016
Table 32: Metered Dose Inhaler Devices Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
Table 33: Metered Dose Inhaler Devices Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 34: Metered Dose Inhaler Devices Market, Germany, Volume (Units), Historic, 2009-2016
Table 35: Metered Dose Inhaler Devices Market, Germany, Volume (Units), Forecast, 2016-2023
Table 36: Metered Dose Inhaler Devices Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 37: Metered Dose Inhaler Devices Market, Germany, Company Share by Revenue ($m), USD Constant, 2016
Table 38: Needle Free Injections Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
Table 39: Needle Free Injections Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 40: Needle Free Injections Market, Germany, Volume (Units), Historic, 2009-2016
Table 41: Needle Free Injections Market, Germany, Volume (Units), Forecast, 2016-2023
Table 42: Needle Free Injections Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 43: Needle Free Injections Market, Germany, Company Share by Revenue ($m), USD Constant, 2016
Table 44: Drug Delivery Devices Market Pipeline Products
Table 45: Dietmar Hopp May Sell its Stake in LTS Lohmann Therapie-Systeme
Table 46: Luye Pharma Acquires Acino and Acino Supply for USD269 Million
Table 47: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer
Table 48: Fresenius Raises USD742.5 Million in Private Placement of 0.875% Notes Due 2022
Table 49: Fresenius Raises USD742.5 Million in Private Placement of 1.5% Notes Due 2024
Table 50: Fresenius Raises USD742.5 Million in Private Placement of 2.125% Notes Due 2027
Table 51: Fresenius Raises USD530.4 Million in Private Placement of 3% Notes Due 2032
Table 52: Magforce Raises USD5.6 Million in Private Placement of Shares
Table 53: Alimera Sciences Enters into Licensing Agreement with pSivida
Table 54: Vetter Pharma International and Microdermics Enter into Agreement
Table 55: Ferring International and Alrise Biosystems Enter into Co-Development Agreement
Table 56: Bluegrass Vascular Enters into Partnership with Merit Medical
Table 57: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs
Table 58: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
Table 59: Propeller Health Enters into Agreement with Novartis Pharma
Table 60: Neuronex Enters Into Licensing Agreement With SK Biopharmaceuticals For DZNS Technology
Table 61: Pfizer Terminates its Licensing Agreement with pSivida
Table 62: BioMed X Enters into Agreement with Merck
Table 63: Bayer Enters into Licensing Agreement with DelSiTech
Table 64: BioCorRx Enters into Licensing Agreement with Therakine
Table 65: AMW Raises USD6.4 Million in Venture Financing

List of Figures
Figure 1: Drug Delivery Devices Market, Germany, Revenue ($m), USD Constant, 2009-2023
Figure 2: Drug Delivery Devices Market, Germany, Revenue Mix ($m), 2016
Figure 3: Drug Delivery Devices Market, Germany, Category Contribution (%), 2016
Figure 4: Drug Delivery Devices Market, Germany, Category Comparison by Revenue ($m), 2009-2023
Figure 5: Drug Delivery Devices Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 6: Drug Delivery Devices Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 7: Drug Delivery Devices Market, Germany, Volume (Units), 2009-2023
Figure 8: Drug Delivery Devices Market, Germany, Volume (Units), Historic, 2009-2016
Figure 9: Drug Delivery Devices Market, Germany, Volume (Units), Forecast, 2016-2023
Figure 10: Drug Delivery Devices Market, Germany, Company Share (%) 2016
Figure 11: Central Venous Catheters Market, Germany, Revenue Mix ($m), 2016
Figure 12: Central Venous Catheters Market, Germany, Segment Contribution (%), 2016
Figure 13: Central Venous Catheters Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 14: Central Venous Catheters Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 15: Central Venous Catheters Market, Germany, Volume (Units), Historic, 2009-2016
Figure 16: Central Venous Catheters Market, Germany, Volume (Units), Forecast, 2016-2023
Figure 17: Central Venous Catheters Market, Germany, Company Share (%) 2016
Figure 18: Infusion Systems Market, Germany, Revenue Mix ($m), 2016
Figure 19: Infusion Systems Market, Germany, Segment Contribution (%), 2016
Figure 20: Infusion Systems Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 21: Infusion Systems Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 22: Ambulatory Infusion Pumps Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 23: Syringe Pumps Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 24: Ambulatory Infusion Pumps Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 25: Syringe Pumps Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 26: Infusion Systems Market, Germany, Volume (Units), Historic, 2009-2016
Figure 27: Infusion Systems Market, Germany, Volume (Units), Forecast, 2016-2023
Figure 28: Ambulatory Infusion Pumps Market, Germany, Volume (Units), Historic, 2009-2016
Figure 29: Syringe Pumps Market, Germany, Volume (Units), Historic, 2009-2016
Figure 30: Ambulatory Infusion Pumps Market, Germany, Volume (Units), Forecast, 2016-2023
Figure 31: Syringe Pumps Market, Germany, Volume (Units), Forecast, 2016-2023
Figure 32: Infusion Systems Market, Germany, Company Share (%) 2016
Figure 33: Metered Dose Inhaler Devices Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 34: Metered Dose Inhaler Devices Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 35: Metered Dose Inhaler Devices Market, Germany, Volume (Units), Historic, 2009-2016
Figure 36: Metered Dose Inhaler Devices Market, Germany, Volume (Units), Forecast, 2016-2023
Figure 37: Metered Dose Inhaler Devices Market, Germany, Company Share (%) 2016
Figure 38: Needle Free Injections Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 39: Needle Free Injections Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 40: Needle Free Injections Market, Germany, Volume (Units), Historic, 2009-2016
Figure 41: Needle Free Injections Market, Germany, Volume (Units), Forecast, 2016-2023
Figure 42: Needle Free Injections Market, Germany, Company Share (%) 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • B. Braun Melsungen AG
  • Teleflex Inc
  • GlaxoSmithKline Plc
  • C. R. Bard Inc
  • Edwards Lifesciences Corp
  • AstraZeneca Plc
  • Boehringer Ingelheim GmbH
  • Pfizer Inc
  • Baxter International Inc
  • Merck & Co Inc
  • Becton Dickinson and Co
  • Fresenius Kabi AG
  • Smiths Medical
  • Medtronic Plc
  • Nipro Corp
  • Hospira Inc
  • Terumo Corp
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll